Rafael Holdings (NYSE:RFL) focuses on advancing cancer care through its support and development of oncology therapeutics. It operates by participating in various projects and investments that aim to bring new treatments from the laboratory to the patient. Rafael Holdings is particularly engaged in identifying promising new therapies and providing the necessary resources to move these innovations forward. The company's objectives include fostering groundbreaking research, partnering with biotech firms with compelling approaches to defeating cancer, and ultimately improving patient outcomes. By leveraging its expertise and resources, Rafael Holdings pursues a vision where its contributions lead to significant advancements in the fight against cancer, aiming to transform the landscape of cancer treatment.